glp-1 food industry news today Weight-loss pill approval set to accelerate product overhauls GLP-1 Drugs: Food Industry Threat

While every person's journey is unique, many of our patients report feeling more in control of their eating habits for the first time

The Found app tracks your progress and connects you with a community for additional accountability

A 2023 study found on a lower dose of GLP-1, participants lost on average 4.8% of lean body mass in just 24 weeks (Jiang et al, 2023)

In some cases, patients may experience feelings of sadness, anxiety, or a general flatness of mood

Resveratrol derived from a traditional Chinese herb, resveratrol delivers potent antioxidant defense in addition to supporting cardiovascular health

Semaglutide is an FDA-approved medication originally developed for type 2 diabetes, but it has also gained recognition for its effectiveness in supporting weight loss